《Pulmonary Pharmacology & Therapeutics》重点专注发布医学-呼吸系统领域的新研究，旨在促进和传播该领域相关的新技术和新知识。鼓励该领域研究者详细地发表他们的高质量实验研究和理论结果。该杂志创刊至今，在医学-呼吸系统领域，有较高影响力，对来稿文章质量要求较高，稿件投稿过审难度较大。欢迎广大同领域研究者投稿该杂志。
| CiteScore | SJR | SNIP | CiteScore排名 | |||
|---|---|---|---|---|---|---|
| 6.2 | 0.786 | 0.675 | 学科类别 | 分区 | 排名 | 百分位 |
|
大类：大类：Medicine
小类：小类：PulmonaryandRespiratoryMedicine
|
Q1 | 39/155 | 75% | |||
|
大类：大类：Medicine
小类：小类：Pharmacology(medical)
|
Q2 | 69/272 | 74% | |||
|
大类：大类：Medicine
小类：小类：Biochemistry(medical)
|
Q2 | 23/72 | 68% | |||
| 按JIF指标学科分区 | 收录子集 | 分区 | 排名 | 百分位 |
|---|---|---|---|---|
| 学科：PHARMACOLOGY & PHARMACY | SCIE | Q2 | 118 / 354 | 66.8% |
| 学科：RESPIRATORY SYSTEM | SCIE | Q2 | 32 / 100 | 68.5% |
| 按JCI指标学科分区 | 收录子集 | 分区 | 排名 | 百分位 |
|---|---|---|---|---|
| 学科：PHARMACOLOGY & PHARMACY | SCIE | Q2 | 116 / 354 | 67.37% |
| 学科：RESPIRATORY SYSTEM | SCIE | Q2 | 34 / 101 | 66.83% |
文章名称
引用次数
Renin-angiotensin-system, a potential pharmacological candidate, in acute respiratory distress syndrome during mechanical ventilation
23
Real-life evaluation of the clinical, functional, and hematological effects of mepolizumab in patients with severe eosinophilic asthma: Results of a single-centre observational study
19
One year of mepolizumab. Efficacy and safety in real-life in Italy
17
Real-life rapidity of benralizumab effects in patients with severe allergic eosinophilic asthma: Assessment of blood eosinophils, symptom control, lung function and oral corticosteroid intake after the first drug dose
14
BLU-5937: A selective P2X3 antagonist with potent anti-tussive effect and no taste alteration
14
Correlations between FEV1 and patient-reported outcomes: A pooled analysis of 23 clinical trials in patients with chronic obstructive pulmonary disease
14
Use of animal models in IPF research
12
The anti-proliferative effects of adiponectin on human lung adenocarcinoma A549 cells and oxidative stress involvement
11
Omalizumab lowers asthma exacerbations, oral corticosteroid intake and blood eosinophils: Results of a 5-YEAR single-centre observational study
11
Safety and efficacy of the human neutrophil elastase inhibitor BAY 85-8501 for the treatment of non-cystic fibrosis bronchiectasis: A randomized controlled trial
11
国家/地区
发文量
TUSA
58
TItaly
47
TCHINA MAINLAND
38
TEngland
37
TGERMANY (FED REP GER)
17
TJapan
15
TCanada
14
TGreece
14
TIndia
13
TSwitzerland
13
